Given the massive cash backing, it would be smart to pull pbt2 out of the cupboard and revisit a way forward for it. So much time and money went into its development and so many positive indicators.
Running side by side trials concurrently with pbt434 would do wonders for the SP and you could make deals with big pharma from a position of strength for a change.
Pran up 70% on Nasdaq pre market, page-16
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $14.25K | 2.930M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 66 | 81346070 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 19609447 | 23 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |